High innate production of interleukin-10 and tumor necrosis factor-α contributes to susceptibility for non-paraneoplastic Lambert-Eaton myasthenic syndrome

被引:4
作者
Wirtz, PW
Huizinga, TWJ
Stoeken, DJ
Wintzen, AR
Verschuuren, JJ
机构
[1] Leiden Univ, Med Ctr, Dept Neurol, NL-2300 RC Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Dept Rheumatol, NL-2300 RC Leiden, Netherlands
[3] Leiden Univ, Med Ctr, Dept Clin Chem, NL-2300 RC Leiden, Netherlands
关键词
Lambert-Eaton myasthenic syndrome; tumor necrosis factor-alpha; interleukin-10; voltage-gated calcium channels;
D O I
10.1016/S0165-5728(03)00205-4
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Non-paraneoplastic Lambert-Eaton myasthenic syndrome (LEMS) is an antibody-mediated autoimmune disorder, in which genetically determined interleukin-10 (11-10) and tumor necrosis factor-alpha (TNF-alpha) could play a role in the susceptibility for the disease. Therefore, we analyzed the production of 11-10 and TNF-a after whole-blood stimulation in first-degree family members of patients with LEMS without malignancy, as a measure of innate production in the patients. Thirty-six first-degree family members of 10 patients and 80 healthy controls were studied. Both 11-10 (p=0.037) and TNF-alpha (p=0.0016) production were increased in the family members, but had no relation with the severity of LEMS or HLA-B8DR3 carriership. Our findings suggest that high innate production of 11-10 and TNF-a is a susceptibility factor for non-paraneoplastic LEMS. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:194 / 197
页数:4
相关论文
共 20 条
[1]  
AAEM Quality Assurance Comm, 2001, MUSCLE NERVE, V24, P1236
[2]   DEFECTIVE LYMPHOCYTE-T FUNCTION IN NONTHYMECTOMIZED PATIENTS WITH MYASTHENIA-GRAVIS [J].
AHLBERG, RE ;
PIRSKANEN, R ;
LEFVERT, AK .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1991, 60 (01) :93-105
[3]   Myasthenia gravis: Diagnosis and follow-up of 100 consecutive patients [J].
Beekman, R ;
Kuks, JBM ;
Oosterhuis, HJGH .
JOURNAL OF NEUROLOGY, 1997, 244 (02) :112-118
[4]  
de Jong BA, 2000, ANN NEUROL, V48, P641, DOI 10.1002/1531-8249(200010)48:4<641::AID-ANA11>3.0.CO
[5]  
2-Z
[6]   TRANSFORMING GROWTH-FACTOR-BETA-1 SUPPRESSES AUTOANTIGEN-INDUCED EXPRESSION OF PRO-INFLAMMATORY CYTOKINES BUT NOT OF INTERLEUKIN-10 IN MULTIPLE-SCLEROSIS AND MYASTHENIA-GRAVIS [J].
LINK, J ;
HE, B ;
NAVIKAS, V ;
PALASIK, W ;
FREDRIKSON, S ;
SODERSTROM, M ;
LINK, H .
JOURNAL OF NEUROIMMUNOLOGY, 1995, 58 (01) :21-35
[7]   Tumor necrosis factor-alpha, lymphotoxin: Interleukin (IL)-6, IL-10, IL-12 and perforin mRNA expression in mononuclear cells in response to acetylcholine receptor is augmented in myasthenia [J].
Matusevicius, D ;
Navikas, V ;
Palasik, W ;
Pirskanen, R ;
Fredrikson, S ;
Link, H .
JOURNAL OF NEUROIMMUNOLOGY, 1996, 71 (1-2) :191-198
[8]   AN IMPROVED DIAGNOSTIC ASSAY FOR LAMBERT-EATON MYASTHENIC SYNDROME [J].
MOTOMURA, M ;
JOHNSTON, I ;
LANG, B ;
VINCENT, A ;
NEWSOMDAVIS, J .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1995, 58 (01) :85-87
[9]   AUTOMATED READING OF PROPIDIUM IODIDE LYMPHOCYTOTOXICITY TESTS FOR HLA-DR, MB, MT TYPING [J].
NAIPAL, AMIH ;
DAMARO, J ;
BRUNING, JW ;
VANLEEUWEN, A ;
VANROOD, JJ .
TISSUE ANTIGENS, 1984, 24 (05) :302-306
[10]   THE LAMBERT-EATON MYASTHENIC SYNDROME - A REVIEW OF 50 CASES [J].
ONEILL, JH ;
MURRAY, NMF ;
NEWSOMDAVIS, J .
BRAIN, 1988, 111 :577-596